首页 | 本学科首页   官方微博 | 高级检索  
     


Kinetically directed combination therapy with adriamycin and X-irradiation in a mammary tumor model
Authors:Paul G Braunschweiger  Larry L Schenken  Lewis M Schiffer
Affiliation:Cancer Research Laboratories, Allegheny Singer Research Corporation, Allegheny General Hospital, Pittsburgh, PA 15212, USA
Abstract:
In the present studies, the interaction of adriamycin (A) and x-irradiation (X) in T1699 mouse mammary tumors was evaluated. Mitotic indices and thymidine labeling indices were determined at various intervals after A or X alone, and after A + X given in combination. The results with A (1.0 mg/kg) and X (200 R) alone suggests that those quantities of each agent induce a G2 progression delay of 9–12 brs. The kinetic results after A + X in combination indicated increased S phase transit. time and G2 progression delay. Recovery kinetics after A + X were used to predict “optimmn” sequence intervals for subsequent A + X fractions. Sequential A + X treatment schedules, up to 4 fractions, were designed and evaluated by regrowth delay measurements. The results indicated that the interaction was additive when A and X were given together in combination. Fractionation of A + X to minimize proliferstive recovery between fractions resulted in an enhanced antitumor effect.
Keywords:X-irradiation  Adriamycin  Cell kinetics  Mammary tumors
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号